Two hope to pick up additional indications for existing blockbuster drugs, while another could score a big victory for a new drug.
News & Analysis: AMAG Pharmaceuticals
AMAG earnings call for the period ending March 31, 2019.
AMAG earnings call for the period ending December 31, 2018.
The company's third-quarter financials did little to inspire confidence that its sales can withstand the launch of generic competition.
AMAG earnings call for the period ending September 30, 2018.
Find out why these two stocks have surged this year to see if there might be more gains ahead.
Favorable regulatory news causes traders to cheer.
Endo International, Genesis Healthcare, AMAG Pharmaceuticals, and MannKind haven't paid off so far this year.
Shares dropped after the company reported mixed top-line data from an important clinical trial.
Investors were hit with a barrage of news today. Here's a look at the key details that investors need to know.